Articles with public access mandates - J. Alan DiehlLearn more
Not available anywhere: 3
SCFs in the new millennium
EK Lee, JA Diehl
Oncogene 33 (16), 2011-2018, 2014
Mandates: US National Institutes of Health
Molecular basis of human diseases and targeted therapy based on small-molecule inhibitors of ER stress-induced signaling pathways
W Rozpedek, A Nowak, D Pytel, J Alan Diehl, I Majsterek
Current Molecular Medicine 17 (2), 118-132, 2017
Mandates: US National Institutes of Health
Use of small-molecule inhibitory compound of PERK-dependent signaling pathway as a promising target-based therapy for colorectal cancer
W Rozpędek, D Pytel, A Wawrzynkiewicz, N Siwecka, A Dziki, Ł Dziki, ...
Current Cancer Drug Targets 20 (3), 223-238, 2020
Mandates: US National Institutes of Health
Available somewhere: 135
The GCN2‐ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation
J Ye, M Kumanova, LS Hart, K Sloane, H Zhang, DN De Panis, ...
The EMBO journal 29 (12), 2082-2096, 2010
Mandates: US National Institutes of Health
The role of the PERK/eIF2α/ATF4/CHOP signaling pathway in tumor progression during endoplasmic reticulum stress
W Rozpedek, D Pytel, B Mucha, H Leszczynska, JA Diehl, I Majsterek
Current molecular medicine 16 (6), 533-544, 2016
Mandates: US National Institutes of Health
Cyclin D1, cancer progression, and opportunities in cancer treatment
S Qie, JA Diehl
Journal of molecular medicine 94, 1313-1326, 2016
Mandates: US National Institutes of Health
Nuclear cyclin D1: an oncogenic driver in human cancer
JK Kim, JA Diehl
Journal of cellular physiology 220 (2), 292-296, 2009
Mandates: US National Institutes of Health
ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth
LS Hart, JT Cunningham, T Datta, S Dey, F Tameire, SL Lehman, BO Qiu, ...
The Journal of clinical investigation 122 (12), 4621-4634, 2012
Mandates: US National Institutes of Health
HIF2α-dependent lipid storage promotes endoplasmic reticulum homeostasis in clear-cell renal cell carcinoma
B Qiu, D Ackerman, DJ Sanchez, B Li, JD Ochocki, A Grazioli, ...
Cancer discovery 5 (6), 652-667, 2015
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damage
E Bobrovnikova-Marjon, C Grigoriadou, D Pytel, F Zhang, J Ye, ...
Oncogene 29 (27), 3881-3895, 2010
Mandates: US National Institutes of Health
PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment
A Avivar-Valderas, E Salas, E Bobrovnikova-Marjon, JA Diehl, C Nagi, ...
Molecular and cellular biology 31 (17), 3616-3629, 2011
Mandates: US National Institutes of Health
A regulated PNUTS mRNA to lncRNA splice switch mediates EMT and tumour progression
S Grelet, LA Link, B Howley, C Obellianne, V Palanisamy, VK Gangaraju, ...
Nature cell biology 19 (9), 1105-1115, 2017
Mandates: US National Institutes of Health
PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation
E Bobrovnikova-Marjon, G Hatzivassiliou, C Grigoriadou, M Romero, ...
Proceedings of the National Academy of Sciences 105 (42), 16314-16319, 2008
Mandates: US National Institutes of Health
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis
S Dey, CM Sayers, II Verginadis, SL Lehman, Y Cheng, GJ Cerniglia, ...
The Journal of clinical investigation 125 (7), 2592-2608, 2015
Mandates: US National Institutes of Health
Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase
P Aggarwal, LP Vaites, JK Kim, H Mellert, B Gurung, H Nakagawa, ...
Cancer cell 18 (4), 329-340, 2010
Mandates: US National Institutes of Health
Selective vulnerability of cancer cells by inhibition of Ca2+ transfer from endoplasmic reticulum to mitochondria
C Cárdenas, M Müller, A McNeal, A Lovy, F Jaňa, G Bustos, F Urra, ...
Cell reports 14 (10), 2313-2324, 2016
Mandates: US National Institutes of Health
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
GS Wong, J Zhou, JB Liu, Z Wu, X Xu, T Li, D Xu, SE Schumacher, ...
Nature medicine 24 (7), 968-977, 2018
Mandates: US National Institutes of Health
IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment
TA Karakasheva, EW Lin, Q Tang, E Qiao, TJ Waldron, M Soni, ...
Cancer Research 78 (17), 4957-4970, 2018
Mandates: US National Institutes of Health
Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment
KV Katlinski, J Gui, YV Katlinskaya, A Ortiz, R Chakraborty, ...
Cancer cell 31 (2), 194-207, 2017
Mandates: US National Institutes of Health
Deletion of p120-catenin results in a tumor microenvironment with inflammation and cancer that establishes it as a tumor suppressor gene
DB Stairs, LJ Bayne, B Rhoades, ME Vega, TJ Waldron, J Kalabis, ...
Cancer cell 19 (4), 470-483, 2011
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program